Abnormal haemostasis and platelet activation occurs in permanent AF patients, and Serkan et al. observed high levels of CXCL4 in the plasma of AF patients (Kamath et al., 2002; Topaloglu et al., 2007). This evidence concerns the gene PF4 and atrial fibrillation.